Open AccessSafety in Japanese Advanced Breast Cancer Patients Who Received Abemaciclib in MONARCH 2 and MONARCH 3: Assessment of Treatment-Emergent Neutropenia, Diarrhea, and Increased Alanine Aminotransferase and Aspartate Aminotransferase Levels
Author(s) -
Norikazu Masuda,
Yucherng Chen,
Tsutomu Kawaguchi,
Koji Dozono,
Masakazu Toi
Publication year - 2022
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s348591
Subject(s) - medicine , neutropenia , adverse effect , fulvestrant , discontinuation , placebo , gastroenterology , diarrhea , breast cancer , cancer , toxicity , estrogen receptor , pathology , alternative medicine